Quince Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2018 | $-3.2M | $-3.2M | — | $13.0K |
| Jun 2018 | $-2.6M | $-2.6M | — | $14.0K |
| Sep 2018 | $-1.9M | $-1.9M | — | $20.0K |
| Dec 2018 | $-4.0M | $-4.0M | — | $108.0K |
| Mar 2019 | $-7.2M | $-7.3M | $51.0K | $190.0K |
| Jun 2019 | $-6.3M | $-6.3M | $-31.0K | $377.0K |
| Sep 2019 | $-8.8M | $-8.8M | $26.0K | $912.0K |
| Dec 2019 | $-11.0M | $-11.0M | $9.0K | $577.0K |
| Mar 2020 | $-10.8M | $-10.8M | $5.0K | $2.0M |
| Jun 2020 | $-14.4M | $-14.4M | $17.0K | $3.4M |
| Sep 2020 | $-12.4M | $-12.4M | $20.0K | $4.2M |
| Dec 2020 | $-13.3M | $-13.3M | $10.0K | $5.0M |
| Mar 2021 | $-13.6M | $-13.6M | $37.0K | $7.0M |
| Jun 2021 | $-17.6M | $-17.7M | $99.0K | $6.8M |
| Sep 2021 | $-17.3M | $-17.3M | $0 | $7.6M |
| Dec 2021 | $-14.4M | $-14.5M | $44.0K | $8.5M |
| Mar 2022 | $-16.1M | $-16.1M | $5.0K | $9.2M |
| Jun 2022 | $-15.4M | $-15.4M | $0 | $5.1M |
| Sep 2022 | $-6.7M | $-6.7M | $50.0K | $694.0K |
| Dec 2022 | $-5.8M | $-5.9M | $78.0K | $1.6M |
| Mar 2023 | $-3.6M | $-3.7M | $136.0K | $1.5M |
| Jun 2023 | $-3.8M | $-3.8M | $0 | $1.3M |
| Sep 2023 | $-4.8M | $-4.8M | $0 | $1.3M |
| Dec 2023 | $-6.1M | $-6.1M | $24.0K | $1.1M |
| Mar 2024 | $-8.4M | $-8.4M | $39.0K | $1.3M |
| Jun 2024 | $-8.7M | $-8.8M | $39.0K | $1.2M |
| Sep 2024 | $-7.3M | $-7.3M | $46.0K | $1.1M |
| Dec 2024 | $-7.6M | $-7.7M | $133.0K | $1.1M |
| Mar 2025 | $-9.6M | $-9.7M | $148.0K | $1.4M |
| Jun 2025 | $-11.4M | $-11.5M | $126.0K | $1.3M |
| Sep 2025 | $-9.9M | $-10.0M | $74.0K | $1.3M |
| Dec 2025 | $-10.5M | $-10.5M | $4.0K | $1.2M |
| Mar 2026 | $-7.6M | $-7.6M | $0 | $1.3M |
| Jun 2026 | $-18.9M | $-18.9M | $0 | $12.1M |